Corbus Pharmaceuticals Holdings, Inc. Deferred Revenue, Revenue Recognized
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Deferred Revenue, Revenue Recognized of $2.89 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2018-11-08
- 2018-09-30: Deferred Revenue, Revenue Recognized 9 month $2.89M.
- 2018-06-30: Deferred Revenue, Revenue Recognized 6 month $1.80M.
| Period end | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month |
|---|---|---|
| 2018-09-30 | $2.89M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.80M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |